Back

prof. dr. H.G.M. (Harry) Heijerman

prof. dr. H.G.M. (Harry) Heijerman

Full Professor

Show full profile

Research Output (96)

Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype

Aalbers B L, Brunsveld J E, van der Ent C K, van den Eijnden J C, Beekman J M, Heijerman H G M 30 Jan 2022, In: Journal of Cystic Fibrosis. 21 , p. 254-257 4 p.

Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation

Burghard Marcella, Takken Tim, Nap-van der Vlist Merel M, Nijhof Sanne L, van der Ent C Kors, Heijerman Harry G M, Hulzebos H J Erik 12 Jan 2022, In: Therapeutic advances in respiratory disease. 16

Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands

Zomer Domenique, van Ingen Jakko, Hofland Regina, Akkerman O. W., Altenburg J., Bakker M., Bannier M. A.G.E., Conemans L. H., Gulmans V. A.M., Heijerman H. G.M., Hoek R. A.S., Janssens H. M., van der Meer R., Merkus P. J.F.M., Noordhoek J. J., Nuijsink M., Terheggen-Lagro S. W.J., van der Vaart H., de Winter-de Groot K. M., 2022, In: Journal of Cystic Fibrosis. 22 , p. 327-333 7 p.

The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trial

Terpstra Lotte C., Altenburg Josje, Mohamed Hoesein Firdaus A., Bronsveld Inez, Go Shirley, van Rijn Philip A.C., De Jong Pim A., Heijerman Harry G.M., Boersma Wim G. 28 Dec 2021, In: Respiratory Medicine. 192 , p. 1-6

Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators

Muilwijk Danya, Bierlaagh Marlou, van Mourik Peter, Kraaijkamp Jasmijn, van der Meer Renske, van den Bor Rutger, Heijerman Harry, Eijkemans René, Beekman Jeffrey, van der Ent Kors 16 Dec 2021, In: Journal of Personalized Medicine. 11 , p. 1-12

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators

Aalbers Bente L, Bronsveld Inez, Hofland Regina W, Heijerman Harry G M 19 Aug 2021, In: Journal of Personalized Medicine. 11 7 p.

Breast development in a 7 year old girl with CF treated with ivacaftor:An indication for personalized dosing?

Jeyaratnam Joshena, van der Meer Renske, Berkers Gitte, Heijerman Harry Gm, Beekman Jeffrey M, van der Ent Cornelis K 23 Jun 2021, In: Journal of Cystic Fibrosis. 20 , p. e63-e66

CFTR Modulators:Does One Dose Fit All?

van der Meer Renske, Wilms Erik B, Heijerman Harry G M Jun 2021, In: Journal of Personalized Medicine. 11 , p. 1-12 12 p.

Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls

van der Meer Renske, Wilms Erik B, Sturm Richart, Heijerman Harry G M 15 May 2021, In: Journal of Cystic Fibrosis. 20 , p. e72-e76

Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation

Kristensen Maartje I, de Winter-de Groot Karin M, Berkers Gitte, Chu Mei Ling J N, Arp Kayleigh, Ghijsen Sophie, Heijerman Harry G M, Arets Hubertus G M, Majoor Christof J, Janssens Hettie M, van der Meer Renske, Bogaert Debby, van der Ent Cornelis K May 2021, In: Journal of Personalized Medicine. 11 , p. 1-9

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not